Global Minds
GlobalMinds led by Akrivia Health, unites researchers, clinicians, health systems and innovators to tackle the world’s most complex mental health and neurodegenerative challenges.
With 50,000+ participants, this precision neuroscience initiative is driving breakthroughs in diagnostics, treatments and care for conditions like depression, schizophrenia, bipolar disorder, Alzheimer’s, and Parkinson’s.
A Unique Global Resource
We are building one of the most comprehensive datasets in neuroscience, combining:
- Genomic data
- Biomarkers
- Deep clinical phenotyping
- Patient-reported outcomes
These insights will accelerate drug discovery, improve diagnosis and transform care delivery worldwide.
Our Mission: Accelerate Mental Health Innovation
GlobalMinds connects the world’s leading experts to transform research and care.
- Bridge care & research
- Power precision medicine
- Speed up, open up research
- Turn real-world data into discovery
Data That Drives Discovery
Through Akrivia’s RLDA platform, Global Minds members can securely access and contribute to one of the world’s most comprehensive mental health datasets, supporting biomarker discovery, early trial design and predictive modelling
Diverse, representative insights – capturing real-world patient journeys across regions, ethnicities and care systems for inclusive R&D
Join the Mental Health R&D Revolution
GlobalMinds brings together healthcare leaders, life sciences, academia and policymakers to shape the future of neuroscience and mental health research.
- Accelerate development of safer, more effective treatments
- Ensure mental health science benefits everyone, everywhere
- Be part of a global, data-driven effort transforming R&D
Let’s build the future of mental health together.